Centre for Nano & Material Sciences, Jain University, Jain Global Campus, Bangalore 562112, Karnataka, India.
Department of Chemistry & Biochemistry, University of Texas at Arlington, Arlington, TX 76019, USA.
Bioorg Chem. 2019 Nov;92:103217. doi: 10.1016/j.bioorg.2019.103217. Epub 2019 Aug 26.
Herein, we describe the successful design and synthesis of seventeen new 1,4-diazinanes, compounds commonly known as piperazines. This group of piperazine derivatives (3a-q) were fully characterized by H NMR, C NMR, FT-IR, and LCMS spectral techniques. The molecular structure of piperazine derivative (3h) was further established by single crystal X-ray diffraction analysis. All reported compounds were evaluated for their antibacterial and antifungal potential against five bacterial (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) and two fungal strains (Candida albicans and Cryptococcus neoformans). The complete bacterial screening results are provided. As documented, piperazine derivative 3e performed the best against these bacteria. Additionally, data obtained during molecular docking studies are very encouraging with respect to potential utilization of these compounds to help overcome microbe resistance to pharmaceutical drugs, as explicitly noted in this manuscript.
在这里,我们描述了十七种新的 1,4-二嗪烷的成功设计和合成,这些化合物通常被称为哌嗪。这组哌嗪衍生物(3a-q)通过 1 H NMR、13 C NMR、FT-IR 和 LCMS 光谱技术进行了全面表征。哌嗪衍生物(3h)的分子结构通过单晶 X 射线衍射分析进一步确定。所有报道的化合物都进行了抗菌和抗真菌评估,针对五种细菌(金黄色葡萄球菌、大肠杆菌、肺炎克雷伯菌、鲍曼不动杆菌和铜绿假单胞菌)和两种真菌(白色念珠菌和新型隐球菌)。提供了完整的细菌筛选结果。如文献所述,哌嗪衍生物 3e 对这些细菌的抑制效果最好。此外,分子对接研究获得的数据非常令人鼓舞,这些化合物有可能被用来帮助克服微生物对药物的耐药性,正如本文明确指出的那样。